The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Technology >> CEO Interviews >> October 23, 2015

Interview with the CEO and President: DigiPath, Inc. (OTCMKTS:DIGP)

Denkin, Todd
Todd Denkin is Founder, Chairman, CEO and President of Digipath, Inc. Since joining Digipath, Inc. in 2014, Mr. Denkin moved the company from a pure digital pathology solution provider into a leader in the medical and recreational cannabis testing market. Digipath Labs’ Las Vegas cannabis testing facility is the number-one testing lab in Nevada. It has been operating since May 2015 and seen a steady increase in clients and revenues. While maintaining the highest standard for cannabis testing, Mr. Denkin also focuses on expanding the business through licensing agreements and partnerships. This brings the reliability, experience and customer service Digipath Labs is known for to cannabis markets across the country. Mr. Denkin’s career has been defined by foresight — the ability to spot and take advantage of emerging market trends and navigate new companies into lucrative markets. In 2009, Mr. Denkin identified a trend in grow-your-own hydroponic systems and co-founded the self-contained hydroponic system leader Phototron Holdings. He helped take the company public and served as its President. At the time, it was one of the very first publicly traded cannabis companies. Starting in the television and film production business since attending the University of Florida, Mr. Denkin became a 25-year show business veteran, making TV shows, commercials, infomercials, music videos and films. It was another natural fit for Mr. Denkin to shift to the internet in 2000 with a streaming video dot-com startup in Las Vegas, Nevada. He helped take that company public in 2003. Profile
TWST: How did DigiPath get its start?

Mr. Denkin: We started off in the digital-pathology space. We have hardware and software solutions for digital pathology. So we have customers that

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy